Gracell Biotechnologies to Participate in Three Investor Conferences in April

Rhea-AI Summary

Gracell Biotechnologies (NASDAQ: GRCL) announced its participation in upcoming investor conferences in April 2022, focusing on advancing its innovative cell therapies for cancer treatment. Key events include the Wells Fargo Biotech Forum on April 12-13 in Palm Beach Gardens, Florida; the Needham Virtual Healthcare Conference on April 14, featuring a presentation at 9:30 am ET; and the UBS Asia Healthcare Virtual Conference on April 27-29. Gracell aims to tackle significant challenges in CAR-T therapies using its advanced technology platforms.

PALO ALTO, Calif. and SUZHOU, China, March 29, 2022 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that the management team will participate in and attend one-on-one meetings at three investor conferences in April 2022 as follows:

Wells Fargo Biotech Forum
One-on-one meetings: April 12 - 13
Location: Palm Beach Gardens, Florida

21^st Annual Needham Virtual Healthcare Conference
One-on-one meetings: April 14
Presentation: April 14, 2022, 9:30 am ET
Webcast link: https://ir.gracellbio.com/news-events/events-and-presentations

The replay of the presentation can be accessed through the “News and Events” section of Gracell’s investor website.

UBS Asia Healthcare Virtual Conference
One-on-one meetings: April 27 - 29

About Gracell
Gracell Biotechnologies Inc. ("Gracell") is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR, TruUCAR and SMART CART™ technology platforms, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal cell quality, high therapy cost and lack of effective CAR-T therapies for solid tumors. For more information on Gracell, please visit www.gracellbio.com. Follow @GracellBio on LinkedIn.

Media contact
Marvin Tang
marvin.tang@gracellbio.com

Investor contact
Gracie Tong
gracie.tong@gracellbio.com

FAQ

What conferences is Gracell participating in April 2022?

Gracell will attend the Wells Fargo Biotech Forum on April 12-13, the Needham Virtual Healthcare Conference on April 14, and the UBS Asia Healthcare Virtual Conference on April 27-29.

What time is Gracell's presentation at the Needham Virtual Healthcare Conference?

Gracell's presentation at the Needham Virtual Healthcare Conference is scheduled for April 14, 2022, at 9:30 am ET.

Where can I access the replay of Gracell's presentation?

The replay of Gracell's presentation can be accessed via the 'News and Events' section of Gracell's investor website.

What technologies does Gracell use in its cancer therapies?

Gracell leverages its FasTCAR, TruUCAR, and SMART CART™ technology platforms to develop innovative cancer therapies.

What is the focus of Gracell Biotechnologies?

Gracell Biotechnologies focuses on discovering and developing affordable and effective cell therapies for cancer treatment.